Dr. Jeffrey A. Lieberman discusses the slow nature of psychotropic drug development, the need for novel treatments, and the recession?s impact on therapeutic advances in psychiatry. Medscape Psychiatry & Mental Health
An NCCN task force will recommend testing for estrogen and progesterone receptors in breast cancer, even though it acknowledges that there are problems with such testing. Medscape Medical News
In contrast to antipsychotics, prior authorization for nonpreferred antidepressants does not appear to have a negative impact on the health of permanently disabled individuals, new research suggests. Medscape Medical News
Postmarketing reports of noncirrhotic portal hypertension, including 4 deaths, have resulted in an update of the didanosine label. Medscape Medical News
Asking patients to return for another office visit may be the only way to be compensated for delivering test results, but is that best for patient care? Medscape Urology
